Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 80

1.

Adrenomedullin as a potential therapeutic agent for inflammatory bowel disease.

Ashizuka S, Inatsu H, Inagaki-Ohara K, Kita T, Kitamura K.

Curr Protein Pept Sci. 2013 Jun;14(4):246-55. Review.

PMID:
23745693
2.

Adrenomedullin treatment reduces intestinal inflammation and maintains epithelial barrier function in mice administered dextran sulphate sodium.

Ashizuka S, Inagaki-Ohara K, Kuwasako K, Kato J, Inatsu H, Kitamura K.

Microbiol Immunol. 2009 Oct;53(10):573-81. doi: 10.1111/j.1348-0421.2009.00159.x.

3.

Impact of adrenomedullin on dextran sulfate sodium-induced inflammatory colitis in mice: insights from in vitro and in vivo experimental studies.

Hayashi Y, Narumi K, Tsuji S, Tsubokawa T, Nakaya MA, Wakayama T, Zuka M, Ohshima T, Yamagishi M, Okada T.

Int J Colorectal Dis. 2011 Nov;26(11):1453-62. doi: 10.1007/s00384-011-1254-0. Epub 2011 Jun 15.

PMID:
21674139
4.

Adrenomedullin Therapy in Patients with Refractory Ulcerative Colitis: A Case Series.

Ashizuka S, Inatsu H, Kita T, Kitamura K.

Dig Dis Sci. 2016 Mar;61(3):872-80. doi: 10.1007/s10620-015-3917-0. Epub 2015 Oct 15.

5.

Adrenomedullin improves intestinal epithelial barrier function by downregulating myosin light chain phosphorylation in ulcerative colitis rats.

Yi Z, Fan H, Liu X, Tang Q, Zuo D, Yang J.

Mol Med Rep. 2015 Sep;12(3):3615-20. doi: 10.3892/mmr.2015.3887. Epub 2015 Jun 3.

PMID:
26043783
6.

Acute and chronic responses associated with adrenomedullin administration in experimental colitis.

Talero E, Sánchez-Fidalgo S, de la Lastra CA, Illanes M, Calvo JR, Motilva V.

Peptides. 2008 Nov;29(11):2001-12. doi: 10.1016/j.peptides.2008.07.013. Epub 2008 Jul 29.

PMID:
18708104
7.

Efficacy of a potent and safe vitamin D receptor agonist for the treatment of inflammatory bowel disease.

Laverny G, Penna G, Vetrano S, Correale C, Nebuloni M, Danese S, Adorini L.

Immunol Lett. 2010 Jun 15;131(1):49-58. doi: 10.1016/j.imlet.2010.03.006. Epub 2010 Mar 27.

PMID:
20350569
8.

Bench-to-bedside pharmacology of adrenomedullin.

Kato J, Kitamura K.

Eur J Pharmacol. 2015 Oct 5;764:140-8. doi: 10.1016/j.ejphar.2015.06.061. Epub 2015 Jul 2. Review.

PMID:
26144371
9.

Anti-inflammatory effects of methanol extract of Patrinia scabiosaefolia in mice with ulcerative colitis.

Cho EJ, Shin JS, Noh YS, Cho YW, Hong SJ, Park JH, Lee JY, Lee JY, Lee KT.

J Ethnopharmacol. 2011 Jul 14;136(3):428-35. doi: 10.1016/j.jep.2010.04.047. Epub 2010 Jun 4.

PMID:
20573566
10.

Adrenomedullin in cardiovascular disease: a useful biomarker, its pathological roles and therapeutic application.

Nishikimi T, Kuwahara K, Nakagawa Y, Kangawa K, Nakao K.

Curr Protein Pept Sci. 2013 Jun;14(4):256-67. Review.

PMID:
23745694
11.

Establishment and validation of a new semi-chronic dextran sulfate sodium-induced model of colitis in mice.

Sha T, Igaki K, Yamasaki M, Watanabe T, Tsuchimori N.

Int Immunopharmacol. 2013 Jan;15(1):23-9. doi: 10.1016/j.intimp.2012.10.022. Epub 2012 Nov 6.

PMID:
23142502
12.

Germ therapy with IL-10 to treat inflammatory bowel diseases.

Michie C.

Mol Med Today. 2000 Nov;6(11):416. No abstract available.

PMID:
11074364
13.

Role of different inflammatory and tumor biomarkers in the development of ulcerative colitis-associated carcinogenesis.

Talero E, Sánchez-Fidalgo S, Villegas I, de la Lastra CA, Illanes M, Motilva V.

Inflamm Bowel Dis. 2011 Mar;17(3):696-710. doi: 10.1002/ibd.21420. Epub 2010 Aug 18.

PMID:
20722052
14.

Therapeutic potential of carbon monoxide (CO) for intestinal inflammation.

Naito Y, Uchiyama K, Takagi T, Yoshikawa T.

Curr Med Chem. 2012;19(1):70-6. Review.

PMID:
22300078
15.

Therapeutic effect of urocortin and adrenomedullin in a murine model of Crohn's disease.

Gonzalez-Rey E, Fernandez-Martin A, Chorny A, Delgado M.

Gut. 2006 Jun;55(6):824-32. Epub 2006 Jan 9.

16.

N-acetylcysteine expresses powerful anti-inflammatory and antioxidant activities resulting in complete improvement of acetic acid-induced colitis in rats.

Uraz S, Tahan G, Aytekin H, Tahan V.

Scand J Clin Lab Invest. 2013 Feb;73(1):61-6. doi: 10.3109/00365513.2012.734859. Epub 2012 Oct 30.

PMID:
23110331
17.

Protective effect of Bauhinia tomentosa on acetic acid induced ulcerative colitis by regulating antioxidant and inflammatory mediators.

Kannan N, Guruvayoorappan C.

Int Immunopharmacol. 2013 May;16(1):57-66. doi: 10.1016/j.intimp.2013.03.008. Epub 2013 Mar 26.

PMID:
23538025
18.

Suppression of Na+/H+ exchanger isoform-3 in human inflammatory bowel disease: lack of reversal by 5'-aminosalicylate treatment.

Siddique I, Hasan F, Khan I.

Scand J Gastroenterol. 2009;44(1):56-64. doi: 10.1080/00365520802321253.

PMID:
18785066
19.

Biodegradable microspheres targeting mucosal immune-regulating cells: new approach for treatment of inflammatory bowel disease.

Nakase H, Okazaki K, Tabata Y, Chiba T.

J Gastroenterol. 2003 Mar;38 Suppl 15:59-62. Review.

PMID:
12698874
20.

Adrenomedullin: a novel therapy for intractable ulcerative colitis.

Ashizuka S, Kita T, Inatsu H, Kitamura K.

Inflamm Bowel Dis. 2013 Feb;19(2):E26-7. doi: 10.1002/ibd.22891. No abstract available.

PMID:
22294498

Supplemental Content

Support Center